biohaven: "rimegepant pivotal phase 3 trial results -- conference call.".
"their serious adverse incident process has been wholly inadequate and what we have heard this week is a damning indictment of the western trust.. april 2015 (20). january 2017 (26).. why novartis� landmark cancer drug approval is great news for bluebird.ben - ?????